EDITORIAL SECTION

Articles

The Competitive Generic Therapy (CGT)

Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical

Market Access Strategies for Pharma Products in Europe: A Comprehensive Guide

The European pharmaceutical market is dynamic and diverse presenting both opportunities and challenges for companies seeking market access This guide delves into effective strategies for navigating the complexities of market access in Europe focusing on key aspects such as reimbursement pricing and overcoming market entry challenges

Cold Chain Logistics for Pharmaceuticals: A Complete Guide to Compliance, Technology, and Best Practices

In the pharmaceutical industry preserving the integrity of temperaturesensitive products is crucial Cold chain logistics for pharmaceuticals play a vital role in ensuring that vaccines biologics and other temperaturesensitive medicines reach patients safely and effectively This complete guide explores pharmaceutical cold chain management focusing on compliance innovative technology and industry be...

Intelligent Collaborations: Navigating the Current Biopharma M&A Rebound

Biopharma MA didnt collapse in and it recalibrated Deal volumes softened valuations compressed and acquirers grew cautious as macroeconomic headwinds elevated interest rates and regulatory scrutiny made largescale consolidation feel riskier than it once had But the underlying drivers never went away They accumulated

Risk Management in Pharmaceutical Manufacturing

The pharmaceutical industry operates under strict regulatory oversight because medicines directly affect patient health and safety Manufacturers must consistently produce products that meet predefined standards of quality safety efficacy identity strength and purity Achieving these objectives requires a proactive approach to identifying and controlling risks throughout the product lifecycle

The Rise of Continuous Clinical Trials: Redefining Drug Development

The conventional clinical trial is a disposable asset A sponsor writes a protocol for a single compound activates a network of sites recruits a control group reads out and then dismantles everything it has built When the next candidate arrives often in the same disease often at the same hospitals

Techno Trends

University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment

Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria

Projects

Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility

Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing

Research Insights

Induction of osteogenic differentiation of MSCs by GSK3β knockdown through GSK3β siRNAs transfection

The development of effective strategies for treating bone defects can be based on gene therapy methods aimed at regulating the differentiation of osteoprogenitor cells One of the approaches is to use siRNA mo

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys